Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
Nakaue E, Teramachi J, Tenshin H, Hiasa M, Harada T, Oda A, Inoue Y, Shimizu S, Higa Y, Sogabe K, Oura M, Hara T, Sumitani R, Maruhashi T, Yamagami H, Endo I, Tanaka E, Abe M. Nakaue E, et al. Among authors: tanaka e. Int J Hematol. 2023 Jul;118(1):88-98. doi: 10.1007/s12185-023-03601-2. Epub 2023 Apr 11. Int J Hematol. 2023. PMID: 37039914 Free PMC article.
GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-alpha converting enzyme (TACE).
Hiasa M, Abe M, Nakano A, Oda A, Amou H, Kido S, Takeuchi K, Kagawa K, Yata K, Hashimoto T, Ozaki S, Asaoka K, Tanaka E, Moriyama K, Matsumoto T. Hiasa M, et al. Among authors: tanaka e. Blood. 2009 Nov 12;114(20):4517-26. doi: 10.1182/blood-2009-04-215020. Epub 2009 Sep 17. Blood. 2009. PMID: 19762488 Free article.
Reinforcement of bond strength of self-etching orthodontic adhesive.
Horiuchi S, Kuroda S, Hiasa M, Suge T, Saku S, Hamada K, Matsuo T, Asaoka K, Tanaka E. Horiuchi S, et al. Among authors: tanaka e. Angle Orthod. 2012 Jan;82(1):30-5. doi: 10.2319/012011-39.1. Epub 2011 Jul 13. Angle Orthod. 2012. PMID: 21751834 Free PMC article.
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.
Hiasa M, Teramachi J, Oda A, Amachi R, Harada T, Nakamura S, Miki H, Fujii S, Kagawa K, Watanabe K, Endo I, Kuroda Y, Yoneda T, Tsuji D, Nakao M, Tanaka E, Hamada K, Sano S, Itoh K, Matsumoto T, Abe M. Hiasa M, et al. Among authors: tanaka e. Leukemia. 2015 Jan;29(1):207-17. doi: 10.1038/leu.2014.147. Epub 2014 May 2. Leukemia. 2015. PMID: 24787487
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration.
Amachi R, Hiasa M, Teramachi J, Harada T, Oda A, Nakamura S, Hanson D, Watanabe K, Fujii S, Miki H, Kagawa K, Iwasa M, Endo I, Kondo T, Yoshida S, Aihara KI, Kurahashi K, Kuroda Y, Horikawa H, Tanaka E, Matsumoto T, Abe M. Amachi R, et al. Among authors: tanaka e. Oncotarget. 2016 Oct 25;7(43):70447-70461. doi: 10.18632/oncotarget.11927. Oncotarget. 2016. PMID: 27626482 Free PMC article.
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects.
Tenshin H, Teramachi J, Oda A, Amachi R, Hiasa M, Bat-Erdene A, Watanabe K, Iwasa M, Harada T, Fujii S, Kagawa K, Sogabe K, Nakamura S, Miki H, Kurahashi K, Yoshida S, Aihara K, Endo I, Tanaka E, Matsumoto T, Abe M. Tenshin H, et al. Among authors: tanaka e. Blood Adv. 2017 Oct 26;1(24):2124-2137. doi: 10.1182/bloodadvances.2017008813. eCollection 2017 Nov 14. Blood Adv. 2017. PMID: 29296860 Free PMC article.
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.
Ashtar M, Tenshin H, Teramachi J, Bat-Erdene A, Hiasa M, Oda A, Tanimoto K, Shimizu S, Higa Y, Harada T, Oura M, Sogabe K, Nakamura S, Fujii S, Sumitani R, Miki H, Udaka K, Takahashi M, Kagawa K, Endo I, Tanaka E, Matsumoto T, Abe M. Ashtar M, et al. Among authors: tanaka e. Cancers (Basel). 2020 Apr 9;12(4):929. doi: 10.3390/cancers12040929. Cancers (Basel). 2020. PMID: 32283857 Free PMC article.
2,340 results